La expansión observada en este mercado se puede atribuir a varios factores, entre ellos, el número sustancial de aprobaciones otorgadas para dispositivos de cierre vascular, la incidencia prevalente de enfermedades cardiovasculares, la creciente prevalencia de la obesidad, el énfasis creciente de las entidades del mercado en dispositivos de cierre vascular de gran calibre, la creciente demografía geriátrica, el panorama favorable de reembolso para procedimientos de radiología intervencionista y el mayor enfoque en el manejo eficaz de la pérdida de sangre durante las intervenciones quirúrgicas. Además, los mercados emergentes presentan perspectivas de crecimiento lucrativas para los participantes del mercado, junto con la proliferación de hospitales y centros quirúrgicos, que en conjunto ofrecen sólidas oportunidades de crecimiento. Sin embargo, desafíos como el requisito de profesionales altamente calificados, los riesgos inherentes asociados con los dispositivos de cierre vascular y el estricto marco regulatorio pueden impedir la expansión del mercado hasta cierto punto. El mercado de dispositivos de cierre vascular está segmentado en función del tipo, el acceso, el procedimiento y la región.
El mercado de dispositivos de cierre vascular (VCD) abarca una variedad de dispositivos médicos diseñados para lograr la hemostasia posterior a procedimientos vasculares mínimamente invasivos, en particular cateterismo cardíaco e intervenciones vasculares periféricas. Estos dispositivos son fundamentales para sellar los sitios de punción dentro de las arterias o venas, mitigando así el riesgo de complicaciones hemorrágicas posteriores al procedimiento. Los VCD presentan claras ventajas sobre las técnicas de compresión manual convencionales, que incluyen una hemostasia acelerada, un tiempo reducido para la deambulación, una menor incomodidad del paciente y estancias hospitalarias más breves.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD) |
| Segmentación | Por tipo, por modo de entrega, uso del modelo |
| Por tipo |
|
| Por modo de entrega |
|
| Por uso del modelo |
|
| Por región |
|
El panorama regulatorio global que rige los dispositivos de cierre vascular se caracteriza por un marco multifacético que comprende estándares, pautas y regulaciones promulgadas por autoridades regulatorias en diferentes naciones y regiones. Entidades como la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA), la Agencia Europea de Medicamentos (EMA) y la Agencia Japonesa de Productos Farmacéuticos y Dispositivos Médicos (PMDA) delinean los requisitos relacionados con la seguridad, eficacia y calidad de los dispositivos de cierre vascular mediante procesos de aprobación previos a la comercialización, mecanismos de vigilancia posterior a la comercialización y evaluaciones de rutina.
The vendor neutral archive market size has crossed USD 374 million in 2020 and will observe a CAGR of more than 5.8% up to 2027 driven by the rising technological advancements in molecular biology, genomics, and microbial diversity.
North America held more than 37% of the vendor neutral archive market revenue share in 2020 and will witness expansion with the surging demand for vendor neutral archive in countries, including U.S. and Canada.
The upcoming trends in the vendor neutral archive market are expansion in the technological advancements in vendor neutral archive will drive industry revenue in the next few years
The global vendor neutral archive market registered a CAGR of 5.8% from 2022 to 2029. The application segment was the highest revenue contributor to the market, with 374 million in 2020, and is estimated to reach 622 million by 2029, with a CAGR of 7%.
Key players profiled in the report include Acuo Technologies (U.S.), Agfa HealthCare (Belgium), BridgeHead Software (U.K.), Carestream Health (U.S.), Dell, Inc. (U.S.), GE Healthcare (U.K.), Fujifilm Corporation (Japan), Merge Health (U.S.), McKesson Corporation (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), and TeraMedica (U.S.).
The healthcare application is expected to increase the most.
North America is the largest regional market for vendor neutral archive.
The two key segments of the PACS market are departmental PACS and enterprise PACS. The vendor-neutral archive market is divided into three types: passive approximators, active approximators, and external hemostatic devices. The market for the vendor-neutral archive is dominated by passive approximators. The growing number of vascular closure device approvals, as well as the numerous benefits connected with these devices, such as ease of use and a lower complication rate in patients, can be attributable to the substantial proportion of this market. Along with the worldwide VNA market, the PACS market is included to provide a comparative overview of both healthcare information systems. The product lifecycles of each of these systems differ greatly. The vendor-neutral archives (VNA) market is thought to be in the same phase (exponential phase) as the PACS market was 10 to 15 years ago. The PACS market, on the other hand, is a mature industry defined by market participants attempting to invest in product innovation and seeking new consumer groups.
The market is divided into three segments based on delivery mode: on-premise VNAs, hybrid VNAs, and entirely cloud-hosted VNAs. Because this approach is preferred over others, on-premise VNAs currently dominate the industry in terms of overall revenue contribution. This choice is due to the superior data control and security afforded by on-premise VNA solutions. However, due to the high capital investment required for on-premise VNAs, hybrid VNA systems that include a cloud-based component for storage are currently attracting the interest of small and medium-sized healthcare facilities. As a result, hybrid VNA solutions are expected to grow faster than on-premise solutions.
The benefits of vendor-neutral archives over PACS in terms of interoperability, flexibility, and accessibility are driving market adoption of VNA technology. In addition, favorable and promising government reforms in the sector of healthcare information technology are encouraging the market. Rising data breaches, the complexity of the VNA idea, the lack of a proper industry-accepted definition of VNAs, and long VNA lifecycles are the key impediments to market expansion (that impact VNA deployment decisions). As a result, the market is poised to witness trends such as VNA integration with EHRs, the use of cloud computing solutions for VNA products, and a holistic approach to providing superior patient care.Picture archiving and communication systems (PACS) are one of the most extensively used technologies in hospitals around the world. PACS is used in more than 80% of hospitals in affluent countries such as the United States, the United Kingdom, and Japan. The scope is visible in developing countries, notably in Asian countries such as India and China. These countries' healthcare facilities are now transitioning from the usage of different services to integrated systems for sharing and storing medical pictures. PACS adoption is fast expanding in these countries as healthcare sectors improve, healthcare expenditure rises, and people become more aware of the need for picture archiving and communication systems. These technologies are generally used in radiology.
The benefit of an active vendor-neutral archive in shortening time to ambulation and hemostasis commanded more than 58 percent of revenue share in 2020. The active vascular closure device employs a variety of ways for direct closure of the artery entry site, including the use of collagen or suture-based materials. Increasing product availability to a bigger population opens up revenue generation opportunities for the segment. Collagen plug devices such as Angio-seal and Mynx, as well as ExoSeal and Starclose devices, are examples of these devices. As a result, more product releases by market participants will benefit segment growth.
Picture archiving and communication systems (PACS) are one of the most extensively used technologies in hospitals around the world. PACS is used in more than 80% of hospitals in affluent countries such as the United States, the United Kingdom, and Japan. The scope is visible in developing countries, notably in Asian countries such as India and China. These countries' healthcare facilities are now transitioning from the usage of different services to integrated systems for sharing and storing medical pictures. PACS adoption is fast expanding in these countries as healthcare sectors improve, healthcare expenditure rises, and people become more aware of the need for picture archiving and communication systems. These technologies are generally used in radiology.
[caption id="attachment_6572" align="aligncenter" width="680"]
The prominent players in the vendor-neutral archive market include Acuo Technologies (U.S.), Agfa HealthCare (Belgium), BridgeHead Software (U.K.), Carestream Health (U.S.), Dell, Inc. (U.S.), GE Healthcare (U.K.), Fujifilm Corporation (Japan), Merge Health (U.S.), McKesson Corporation (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), and TeraMedica (U.S.).
The vendor-neutral archive market is divided into major regions- North America, Europe, South America, Asia Pacific, and middle east & Africa. North America is the largest regional segment in 2021.
When compared to other regional markets, the North America market is predicted to lead the global vendor neutral archive market with a greater revenue share, and this dominance is expected to continue during the forecast period. This might be ascribed to the region's well-developed healthcare industry and the presence of important market participants. Europe has the second-largest revenue share in the global vendor neutral archive market, followed by Asia Pacific, Latin America, and the Middle East and Africa, in that order. The Asia Pacific market is expected to grow the fastest in terms of revenue, owing to increased adoption of imaging in various departments such as cardiology, pathology, oncology, and dermatology, as well as increased government initiatives for the development of healthcare sector in emerging markets.
[caption id="attachment_6573" align="aligncenter" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.